Newsfeeds - Spark Newswire

2 minute read

Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb

Today, 9:28 AM

Toward the end of trading Tuesday, the Dow traded down 0.87% to 34,565.88 while the NASDAQ fell 0.46% to 15,035.39. The S&P also fell, dropping 0.60% to 4,441.76.

ADGI

2 minute read

Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide

By Lisa Levin

Today, 9:28 AM

Midway through trading Tuesday, the Dow traded down 0.49% to 34,698.16 while the NASDAQ fell 0.05% to 15,098.38. The S&P also fell, dropping 0.24% to 4,458.05.

BLU

3 minute read

36 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 9:28 AM

Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results.

ACH

2 minute read

Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August

By Lisa Levin

Today, 9:28 AM

Following the market opening Tuesday, the Dow traded down 0.26% to 34,778.27 while the NASDAQ rose 0.01% to 15,106.84. The S&P also fell, dropping 0.20% to 4,459.89.

AZRX

6 minute read

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen’s Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout

By Shanthi Rexaline

Today, 9:28 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13)

ABT

1 minute read

HC Wainwright & Co. Maintains Buy on BELLUS Health, Raises Price Target to $14

By vishwanath@benzinga.com

Today, 9:28 AM

HC Wainwright & Co. analyst Andrew Fein maintains BELLUS Health (NASDAQ:BLU) with a Buy and raises the price target from $10 to $14.

BLU

6 minute read

72 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:28 AM

Gainers

ACH

1 minute read

What’s Going On With BELLUS Health’s Stock Today?

By Adam Eckert

Today, 9:28 AM

BELLUS Health Inc (NASDAQ: BLU) is trading higher Monday after the company announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractory chronic cough. The stock is experiencing high volatility, trading as high as $4.78 and as low as $3.63 in today's session.

BLU

1 minute read

Pre-Market Outlook

Benzinga Pro’s Top 5 Stocks To Watch For Monday, Sept. 13, 2021: JKS, NEGG, DVAX, BLU, MDXG

By Benzinga Newsdesk

Today, 9:28 AM

Today's 5 Stock Ideas: JinkoSolar Holding Co (JKS) - JinkoSolar reports Q2 earnings on Wednesday, September 15th. Newegg Commerce (NEGG) - Shares up ~2.50% premarket. The company provided 2H and

BLU

1 minute read

BELLUS Health Stock Shines After Refractory Chronic Cough Trial Data

By Vandana Singh

Today, 9:28 AM

BELLUS Health Inc (NASDAQ:BLU) has announced a positive interim analysis from Phase 2b SOOTHE trial of BLU-5937 for refractory chronic cough…

BLU